Clinical Trials in Sweden

• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 Phase III Locally Advanced or Metastatic Cholangiocarcinoma Servier Affaires Medicales
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• Clinical validation study of urinary clusterin and EGF in patients with chronic kidney disease Not authorised
  2023-507449-27-00 Phase IV Chronic kidney disease Steno Diabetes Center Copenhagen
• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Not authorised
  2024-514496-18-00 Phase I (Other) Hepatocellular carcinoma, renal cell carcinoma and different… Disruptive Pharma AB
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 Phase III Focal cerebral arteriopathy and childhood stroke Focal cereb… Insel Gruppe AG
• Comparison of creams for the treatment of dry foot of persons with diabetes. Pending
  2022-500907-27-01 Phase IV xerotic skin on foot of subjects with diabetes Malmö Universitet
• Early intervention and recovery of sexual function in men and women after treatment of rectal cancer–a randomized placebo-controlled study w… Pending
  2023-504592-24-00 Phase II sexual/ erectile function in women and men after treatment f… Karolinska Institutet
• Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending
  2023-504654-35-00 Phase II Graves Ofthalmopathy Region Skane
• A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients Pending
  2023-504846-73-01 Phase II Glioblstoma WHO grade IV Karolinska Institutet
• Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolism Pending
  2023-505726-34-02 Phase IV Healthy volunteers Karolinska University Hospital
• An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerabilit… Pending
  2023-506865-71-00 Phase I (FiH) Relapsed/Refractory Acute Myeloid Leukemia (AML) CanCell Therapeutics
• Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CR… Pending
  2023-508496-37-00 Phase II Carcinomatosis of peritoneal cavity Oncoinvent Solutions AS
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 Phase III/IV Obesity and T2D Novo Nordisk A/S
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 Phase III Relapsed Acute Lymphoblastic Leukemia (ALL) Charite Universitaetsmedizin Berlin KöR
• HEMO trial - A randomized controlled trial of heparin bolus mobilization prior to peripheral hematopoietic cell collection from patients wit… Pending
  2023-509534-18-01 Phase II Myelom Karolinska University Hospital
• Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending
  2024-511054-50-00 Phase II/III HIV-1 Infection Gilead Sciences Inc.
• A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending
  2024-512195-35-00 Phase III Stage I adenocarcinoma non-small cell lung cancer (NSCLC) wi… AstraZeneca AB
• A multicentre, prospective, open-label study with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predi… Pending
  2024-512721-89-00 Phase II Breast Cancer Karolinska University Hospital
• The Synergism Or Long Duration (SOLD) Study Pending
  2024-512884-30-00 Phase III breast cancer HUS-Yhtymae
• A randomized, double-blind, placebo-controlled, 104-week proof-of-concept study to evaluate the efficacy of intravenous prasinezumab in part… Pending
  2024-513496-40-00 Phase II PARKINSON’S DISEASE Universitaetsklinikum Tuebingen AöR
• GLUTAMICS III Pending
  2024-513575-40-01 Phase III Acute kidney injury and heart failure after coronary artery … Region Oestergoetland

Showing 1–24 of 1,111 trials